Retinoblastoma-binding Protein 9 Suppresses Intestinal Inflammation and Inflammation-induced Tumorigenesis in Mice

被引:0
作者
Hamada, Kensuke [1 ]
Nakanishi, Yuki [1 ]
Muta, Yu [1 ]
Omatsu, Mayuki [1 ]
Iwane, Kosuke [1 ]
Ikeda, Munehiro [1 ]
Chen, Jiayu [1 ]
Masui, Yoko [1 ]
Aoyama, Naoki [1 ]
Agatsuma, Nobukazu [1 ]
Yamakawa, Go [1 ]
Utsumi, Takahiro [1 ]
Kitamoto, Hiroki [1 ]
Okabe, Makoto [1 ]
Itatani, Yoshiro [2 ]
Adachi, Takumi [3 ]
Yasuda, Koubun [3 ]
Yamamoto, Shuji [1 ]
Fukuda, Akihisa [1 ]
Kuroda, Etsushi [3 ]
Ohmuraya, Masaki [4 ]
Obama, Kazutaka [2 ]
Hirota, Seiichi [5 ]
Ikeuchi, Hiroki [6 ]
Nakanishi, Kenji [3 ]
Seno, Hiroshi [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 54 Shogoin Kawahara cho,Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Gastrointestinal Surg, Kyoto, Japan
[3] Hyogo Med Univ, Sch Med, Dept Immunol, Nishinomiya, Japan
[4] Hyogo Med Univ, Sch Med, Dept Genet, Nishinomiya, Japan
[5] Hyogo Med Univ, Sch Med, Dept Surg Pathol, Nishinomiya, Japan
[6] Hyogo Med Univ, Sch Med, Dept Gastroenterol Surg, Nishinomiya, Japan
来源
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2025年 / 19卷 / 03期
关键词
Colitis-associated Cancer; Interferon Signaling; Reti- noblastoma-binding Protein 9; Ulcerative Colitis; BOWEL-DISEASE; MAMMALIAN TARGET; EPITHELIAL-CELLS; BARRIER FUNCTION; COLITIS; ACTIVATION; STAT3; REPRESSION; APOPTOSIS; SURVIVAL;
D O I
10.1016/j.jcmgh.2024.101435
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Retinoblastoma-binding protein 9 (RBBP9) was initially reported as cell cycle regulator via RB/E2F. Accumulating evidence has revealed the importance of RBBP9 in physiological and pathological states including inflammatory disease. However, the functional role of RBBP9 in ulcerative colitis (UC) and colitis-associated cancer (CAC) remains elusive. Methods: Human samples of UC and CAC were examined by immunohistochemical and bioinformatics analyses. We established dextran sodium sulfate (DSS)-induced colitis, azoxymethane (AOM)/DSS-induced CAC model, and Apc(Min/+) sporadic tumor model using wild-type and Rbbp9(-/-) mice. RNA sequencing was analyzed to identify the phenotype alternation upon Rbbp9 deletion. In addition, genetic and pharmacological inhibition of the Janus kinase (JAK)/signal transducer and activator of transcription 1 (STAT1) pathway was performed. Results: The expression of RBBP9 was reduced in human UC and CAC samples. The loss of RBBP9 enhanced the activation of interferon (IFN)/JAK/STAT1 signaling, resulting in susceptibility to DSS-induced colitis and AOM/DSS-induced CAC tumors by increasing epithelial cell apoptosis and immune activation. An in vitro kinase assay revealed that RBBP9 directly regulated JAK/STAT1 signaling by suppressing STAT1 phosphorylation. A positive feedback loop involving epithelial cell apoptosis, commensal microbiome invasion, and activation of submucosal immune activity was identified in Rbbp9(-/-) mouse intestines through enhanced JAK/STAT1 signaling in RBBP9-deficient epithelial cells and macrophages. The genetic inhibition of STAT1 or treatment with the JAK/STAT inhibitor reversed epithelial cell apoptosis and mitigated the enhanced susceptibility to DSS-induced colitis in Rbbp9(-/-) mice. Conclusions: RBBP9 suppresses the intestinal inflammation by negatively regulating JAK/STAT1 signaling pathway.
引用
收藏
页数:20
相关论文
共 42 条
[1]   Lung fibroblasts produce IL-33 in response to stimulation with retinoblastoma-binding protein 9 via production of prostaglandin E2 [J].
Adachi, Takumi ;
Yasuda, Koubun ;
Muto, Taichiro ;
Serada, Satoshi ;
Yoshimoto, Tomohiro ;
Ishii, Ken J. ;
Kuroda, Etsushi ;
Araki, Kimi ;
Ohmuraya, Masaki ;
Naka, Tetsuji ;
Nakanishi, Kenji .
INTERNATIONAL IMMUNOLOGY, 2020, 32 (10) :637-652
[2]   Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes [J].
Bachovchin, Daniel A. ;
Brown, Steven J. ;
Rosen, Hugh ;
Cravatt, Benjamin F. .
NATURE BIOTECHNOLOGY, 2009, 27 (04) :387-394
[3]   IL-6 prevents Th2 cell polarization by promoting SOCS3-dependent suppression of IL-2 signaling [J].
Bachus, Holly ;
McLaughlin, Erin ;
Lewis, Crystal ;
Papillion, Amber M. ;
Benveniste, Etty N. ;
Hill, Dave Durell ;
Rosenberg, Alexander F. ;
Ballesteros-Tato, Andre ;
Leon, Beatriz .
CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (06) :651-665
[4]   Evolutionary history of human colitis-associated colorectal cancer [J].
Baker, Ann-Marie ;
Cross, William ;
Curtius, Kit ;
Al Bakir, Ibrahim ;
Choi, Chang-Ho Ryan ;
Davis, Hayley Louise ;
Temko, Daniel ;
Biswas, Sujata ;
Martinez, Pierre ;
Williams, Marc J. ;
Lindsay, James O. ;
Feakins, Roger ;
Vega, Roser ;
Hayes, Stephen J. ;
Tomlinson, Ian P. M. ;
McDonald, Stuart A. C. ;
Moorghen, Morgan ;
Silver, Andrew ;
East, James E. ;
Wright, Nicholas A. ;
Wang, Lai Mun ;
Rodriguez-Justo, Manuel ;
Jansen, Marnix ;
Hart, Ailsa L. ;
Leedham, Simon J. ;
Graham, Trevor A. .
GUT, 2019, 68 (06) :985-995
[5]   gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis [J].
Bollrath, Julia ;
Phesse, Toby J. ;
von Burstin, Vivian A. ;
Putoczki, Tracy ;
Bennecke, Moritz ;
Bateman, Trudie ;
Nebelsiek, Tim ;
Lundgren-May, Therese ;
Canli, Oezge ;
Schwitalla, Sarah ;
Matthews, Vance ;
Schmid, Roland M. ;
Kirchner, Thomas ;
Arkan, Melek C. ;
Ernst, Matthias ;
Greten, Florian R. .
CANCER CELL, 2009, 15 (02) :91-102
[6]   Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers [J].
Chatila, Walid K. ;
Walch, Henry ;
Hechtman, Jaclyn F. ;
Moyer, Sydney M. ;
Sgambati, Valeria ;
Faleck, David M. ;
Srivastava, Amitabh ;
Tang, Laura ;
Benhamida, Jamal ;
Ismailgeci, Dorina ;
Campos, Carl ;
Wu, Fan ;
Chang, Qing ;
Vakiani, Efsevia ;
de Stanchina, Elisa ;
Weiser, Martin R. ;
Widmar, Maria ;
Yantiss, Rhonda K. ;
Shah, Manish A. ;
Bass, Adam J. ;
Stadler, Zsofia K. ;
Katz, Lior H. ;
Mellinghoff, Ingo K. ;
Sethi, Nilay S. ;
Schultz, Nikolaus ;
Ganesh, Karuna ;
Kelsen, David ;
Yaeger, Rona .
NATURE COMMUNICATIONS, 2023, 14 (01)
[7]  
Constant David A, 2022, Immunohorizons, V6, P416, DOI 10.4049/immunohorizons.2200025
[8]   A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis [J].
Deng, Lin ;
Zhou, Jin-Feng ;
Sellers, Rani S. ;
Li, Jiu-Feng ;
Nguyen, Andrew V. ;
Wang, Yubao ;
Orlofsky, Amos ;
Liu, Qiang ;
Hume, David A. ;
Pollard, Jeffrey W. ;
Augenlicht, Leonard ;
Lin, Elaine Y. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (02) :952-967
[9]   Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features [J].
Flanagan, Dustin J. ;
Amirkhah, Raheleh ;
Vincent, David F. ;
Gunduz, Nuray ;
Gentaz, Pauline ;
Cammareri, Patrizia ;
McCooey, Aoife J. ;
McCorry, Amy M. B. ;
Fisher, Natalie C. ;
Davis, Hayley L. ;
Ridgway, Rachel A. ;
Lohuis, Jeroen ;
Leach, Joshua D. G. ;
Jackstadt, Rene ;
Gilroy, Kathryn ;
Mariella, Elisa ;
Nixon, Colin ;
Clark, William ;
Hedley, Ann ;
Markert, Elke K. ;
Strathdee, Douglas ;
Bartholin, Laurent ;
Redmond, Keara L. ;
Kerr, Emma M. ;
Longley, Daniel B. ;
Ginty, Fiona ;
Cho, Sanghee ;
Coleman, Helen G. ;
Loughrey, Maurice B. ;
Bardelli, Alberto ;
Maughan, Timothy S. ;
Campbell, Andrew D. ;
Lawler, Mark ;
Leedham, Simon J. ;
Barry, Simon T. ;
Inman, Gareth J. ;
van Rheenen, Jacco ;
Dunne, Philip D. ;
Sansom, Owen J. .
NATURE COMMUNICATIONS, 2022, 13 (01)
[10]   IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer [J].
Grivennikov, Sergei ;
Karin, Eliad ;
Terzic, Janos ;
Mucida, Daniel ;
Yu, Guann-Yi ;
Vallabhapurapu, Sivakumar ;
Scheller, Juergen ;
Rose-John, Stefan ;
Cheroutre, Hilde ;
Eckmann, Lars ;
Karin, Michael .
CANCER CELL, 2009, 15 (02) :103-113